These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 12567248)

  • 1. Isolation, characterization, and antifungal susceptibility of melanin-deficient mutants of Scedosporium prolificans.
    Ruiz-Díez B; Martínez-Suárez JV
    Curr Microbiol; 2003 Mar; 46(3):228-32. PubMed ID: 12567248
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Population-based surveillance for scedosporiosis in Australia: epidemiology, disease manifestations and emergence of Scedosporium aurantiacum infection.
    Heath CH; Slavin MA; Sorrell TC; Handke R; Harun A; Phillips M; Nguyen Q; Delhaes L; Ellis D; Meyer W; Chen SC;
    Clin Microbiol Infect; 2009 Jul; 15(7):689-93. PubMed ID: 19549223
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Infection and colonisation due to Scedosporium in Northern Spain. An in vitro antifungal susceptibility and molecular epidemiology study of 60 isolates.
    Lackner M; Rezusta A; Villuendas MC; Palacian MP; Meis JF; Klaassen CH
    Mycoses; 2011 Oct; 54 Suppl 3():12-21. PubMed ID: 21995658
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence and susceptibility testing of new species of pseudallescheria and scedosporium in a collection of clinical mold isolates.
    Alastruey-Izquierdo A; Cuenca-Estrella M; Monzón A; Rodriguez-Tudela JL
    Antimicrob Agents Chemother; 2007 Feb; 51(2):748-51. PubMed ID: 17101671
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeted Disruption of Melanin Biosynthesis Genes in the Human Pathogenic Fungus Lomentospora prolificans and Its Consequences for Pathogen Survival.
    Al-Laaeiby A; Kershaw MJ; Penn TJ; Thornton CR
    Int J Mol Sci; 2016 Mar; 17(4):444. PubMed ID: 27023523
    [TBL] [Abstract][Full Text] [Related]  

  • 6. GROWTH-INHIBITORY EFFECTS OF FARNESOL AGAINST SCEDOSPORIUM BOYDII AND LOMENTOSPORA PROLIFICANS.
    Pumeesat P; Wongsuk T; Muangkaew W; Luplertlop N
    Southeast Asian J Trop Med Public Health; 2017 Jan; 48(1):170-8. PubMed ID: 29644833
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activity and post antifungal effect of chlorpromazine and trifluopherazine against Aspergillus, Scedosporium and zygomycetes.
    Vitale RG; Afeltra J; Meis JF; Verweij PE
    Mycoses; 2007 Jul; 50(4):270-6. PubMed ID: 17576318
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro activities of 35 double combinations of antifungal agents against Scedosporium apiospermum and Scedosporium prolificans.
    Cuenca-Estrella M; Alastruey-Izquierdo A; Alcazar-Fuoli L; Bernal-Martinez L; Gomez-Lopez A; Buitrago MJ; Mellado E; Rodriguez-Tudela JL
    Antimicrob Agents Chemother; 2008 Mar; 52(3):1136-9. PubMed ID: 18195067
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Conidial germination in Scedosporium apiospermum, S. aurantiacum, S. minutisporum and Lomentospora prolificans: influence of growth conditions and antifungal susceptibility profiles.
    Mello TP; Aor AC; Oliveira SS; Branquinha MH; Santos AL
    Mem Inst Oswaldo Cruz; 2016 Jun; 0(7):0. PubMed ID: 27355215
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The in vitro susceptibility of Scedosporium prolificans to ajoene, allitridium and a raw extract of garlic (Allium sativum).
    Davis SR; Perrie R; Apitz-Castro R
    J Antimicrob Chemother; 2003 Mar; 51(3):593-7. PubMed ID: 12615859
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence of Scedosporium species and Lomentospora prolificans in patients with cystic fibrosis in a multicenter trial by use of a selective medium.
    Sedlacek L; Graf B; Schwarz C; Albert F; Peter S; Würstl B; Wagner S; Klotz M; Becker A; Haase G; Laniado G; Kahl B; Suerbaum S; Seibold M; Tintelnot K
    J Cyst Fibros; 2015 Mar; 14(2):237-41. PubMed ID: 25595044
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antifungal activity against Scedosporium species and novel assays to assess antifungal pharmacodynamics against filamentous fungi.
    Wiederhold NP; Lewis RE
    Med Mycol; 2009 Jun; 47(4):422-32. PubMed ID: 19058049
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fusarium species,Scedosporium species, and Lomentospora prolificans: A systematic review to inform the World Health Organization priority list of fungal pathogens.
    Marinelli T; Kim HY; Halliday CL; Garnham K; Bupha-Intr O; Dao A; Morris AJ; Alastruey-Izquierdo A; Colombo A; Rickerts V; Perfect J; Denning DW; Nucci M; Hamers RL; Cassini A; Oladele R; Sorrell TC; Ramon-Pardo P; Fusire T; Chiller TM; Wahyuningsih R; Forastiero A; Al-Nuseirat A; Beyer P; Gigante V; Beardsley J; Sati H; Alffenaar JW; Morrissey CO
    Med Mycol; 2024 Jun; 62(6):. PubMed ID: 38935914
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Case reports. Transient colonization with Scedosporium prolificans. Report of four cases in Madrid.
    del Palacio A; Garau M; Amor E; Martinez-Alonso I; Calvo T; Carrillo-Muñoz A; Guarro J
    Mycoses; 2001; 44(7-8):321-5. PubMed ID: 11714069
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative study of the in vitro activity of various antifungal drugs against Scedosporium spp. in aerobic and hyperbaric atmosphere versus normal atmosphere.
    Farina C; Marchesi G; Passera M; Diliberto C; Russello G
    J Mycol Med; 2012 Jun; 22(2):142-8. PubMed ID: 23518016
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New record of Scedosporium dehoogii from Chile: Phylogeny and susceptibility profiles to classic and novel putative antifungal agents.
    Alvarez E; Sanhueza C
    Rev Iberoam Micol; 2016; 33(4):224-229. PubMed ID: 27461998
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of biofilm formation and azoles' susceptibility in Scedosporium/Lomentospora species using an in vitro model that mimics the cystic fibrosis patients' airway environment.
    Mello TP; Lackner M; Branquinha MH; Santos ALS
    J Cyst Fibros; 2021 Mar; 20(2):303-309. PubMed ID: 33334714
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pathobiology of Lomentospora prolificans: could this species serve as a model of primary antifungal resistance?
    Pellon A; Ramirez-Garcia A; Buldain I; Antoran A; Martin-Souto L; Rementeria A; Hernando FL
    Int J Antimicrob Agents; 2018 Jan; 51(1):10-15. PubMed ID: 28669833
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fungemia due to Scedosporium prolificans: a description of two cases with fatal outcome.
    Simarro E; Marín F; Morales A; Sanz E; Pérez J; Ruiz J
    Clin Microbiol Infect; 2001 Nov; 7(11):645-7. PubMed ID: 11737092
    [TBL] [Abstract][Full Text] [Related]  

  • 20. N-Chlorotaurine Exhibits Fungicidal Activity against Therapy-Refractory Scedosporium Species and Lomentospora prolificans.
    Lackner M; Binder U; Reindl M; Gönül B; Fankhauser H; Mair C; Nagl M
    Antimicrob Agents Chemother; 2015 Oct; 59(10):6454-62. PubMed ID: 26239996
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.